Ultragenyx Pharmaceutical Inc.

RARE ·Healthcare, Drug Manufacturers - General, United States

← 5Y 10Y MAX →

Returns on Capital

ROE ROI ROA

Fiscal Year	ROE	ROI	ROA
FY2024	-223.1%	-223.1%	-37.9%
FY2025	718.8%	718.8%	-37.5%